Moolec Science (MLEC) Net Equity Issued and Repurchased (2023 - 2024)

Moolec Science (MLEC) reported Net Equity Issued and Repurchased of $15.0 million for Q4 2024, up 854.16% sequentially from -$2.0 million in Q1 2023.

Moolec Science (MLEC) Net Equity Issued and Repurchased (2023 - 2024) Analysis & Trends

Moolec Science (MLEC) has 2 years of Net Equity Issued and Repurchased data on file, last reported at $15.0 million in Q4 2024.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Net Equity Issued and Repurchased (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	163.10 Mn
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	141.90 Mn
10	Moolec Science	5.21 Bn	5.21 Bn	-	-

Download Data